Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02056964 · ClinicalTrials.gov registry record
HEART Pathway Implementation
A clinical trial of Acute Coronary Syndrome and Chest Pain, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 14,717
- Enrollment target
- 1
- Study location
NCT02056964: Completed study of Acute Coronary Syndrome and Chest Pain, sponsored by Wake Forest University Health Sciences.
NCT02056964 is a study of Acute Coronary Syndrome and Chest Pain that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 14,717 participants, above the 2,354-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (525% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02056964, a study of Acute Coronary Syndrome and Chest Pain, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 14,717 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effectiveness of the HEART Pathway, a clinical decision aid for the care of patients with chest pain, in a "real-world" clinical setting. This will be accomplished through the building of a transformative collaboration between research, education, and health systems operations to more effectively and efficiently provide patient care.
Conditions Studied
Study Locations (1)
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,717 participants |
| Start Date | 2013-11 |
| Est. Completion | 2019-01-31 |
What the finished NCT02056964 record still lists
NCT02056964 is an observational study that tracks outcomes without assigning an intervention. Its 14,717 participants enrollment target places it among the larger protocols in the corpus, above the 2,354-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (525% higher).
The record links to 4 conditions, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT02056964 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02056964 about?
NCT02056964 is a clinical study titled "HEART Pathway Implementation". The purpose of this study is to determine the effectiveness of the HEART Pathway, a clinical decision aid for the care of patients with chest pain, in a "real-world" clinical setting. This will be accomplished through the building of a transformative collaboration between research, education, and he...
What is the current status of trial NCT02056964?
This trial is currently completed. The enrollment target is 14,717 participants. The study started on 2013-11. Estimated completion is 2019-01-31.
What conditions does trial NCT02056964 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome, Chest Pain, Chest Pain Atypical Syndrome, Chest Pain Rule Out Myocardial Infarction.
Who is sponsoring clinical trial NCT02056964?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02056964 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02056964's enrollment target sits among peer trials
14,717 3rd of 40 higher than 38 of 40 other Acute Coronary Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Coronary Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Polypill for Acute Coronary Syndrome
RECRUITING · Phase 2
-
Positive Emotions Following Acute Cardiac Events
RECRUITING · NA
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
-
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
RECRUITING · Phase 3
-
A Prospective Research Investigation of Ischemia Using MCG
RECRUITING
-
AngelMed Guardian® System PMA Post Approval Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06849869 · 14,820 participants · NA
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
- NCT05359016 · 14,600 participants · NA
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia